← Front pageWatch · Archive
DRASKER

LIVE STORY PAGE

DEVELOPING2 reporting sourcesRevision 1

"Consider Discontinuing": FDA Slaps "Eye Stroke" Warning On All GLP-1 Weight-Loss Drugs

"Consider Discontinuing": FDA Slaps "Eye Stroke" Warning On All GLP-1 Weight-Loss Drugs The FDA is requiring the makers of every GLP-1 drug on the U.S. market, Ozempic, Wegovy, Mounjaro and Zepbound among them, to warn of a potential

What changed: Drasker began tracking this story across 2 reporting sources. Drasker last checked the live reporting Nov 10, 2026, 2:30 AM EST.
MEANINGFUL UPDATES
LATEST

Drasker began tracking this story across 2 reporting sources.

LATEST REPORTING

Checking for new reporting every two minutes.